Back to companies

Annovis Bio, Inc.

ANVSUSNYSEPharmaceuticals & Healthcare

Annovis Bio, Inc.

Revenue
—
FY2025
Operating income
-$29.7mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API